Showing results (11-20 of 112) with videos related to
Sort By:
Pageof 12
Journal of the Chinese Medical Association : JCMA|December 4, 2020
Precipitating factors causing hyperbilirubinemia during chronic hepatitis C treatment with paritaprevir/ritonavir/ombitasvir and dasabuvirYi-Kai Wang, Wei-Ping Lee, Ying-Wen Wang, et al.Annals of Medicine|June 3, 2024
Safety and effectiveness of remdesivir in hospitalized patients with COVID-19 and severe renal impairment: experience at a large medical centerHsuan-Yu Chang, Chia-Chen Hsu, Li-Fang Hu, et al.Journal of Thrombosis and Thrombolysis|July 15, 2023
Effectiveness and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation and advanced kidney diseaseChia-Chen Hsu, Cheng-Chi Chen, Chian-Ying Chou, et al.Clinical Nephrology|January 11, 2018
Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosusTzu-Han Yang, Tsai-Hung Wu, Yuh-Lih Chang, et al.International Journal of Molecular Sciences|July 18, 2015
Poly(ADP-Ribose) Polymerase 1: Cellular Pluripotency, Reprogramming, and TumorogenesisBo-Hua Jiang, Wei-Lien Tseng, Hsin-Yang Li, et al.Healthcare (Basel, Switzerland)|December 29, 2020
Epidemiologic Analysis of Taiwanese Patients with Idiopathic Pulmonary FibrosisSheau-Ning Yang, Diahn-Warng Perng, Hsin-Kuo Ko, et al.Plos One|August 15, 2022
Drug-related problem characterization and the solved status associated factor analysis in a pharmacist-managed anticoagulation clinicJu-Chieh Wung, Hsin-Chung Lin, Chia-Chen Hsu, et al.Journal of Vascular Surgery|August 2, 2014
Ginkgo biloba extract inhibits oxidized low-density lipoprotein (oxLDL)-induced matrix metalloproteinase activation by the modulation of the lectin-like oxLDL receptor 1-regulated signaling pathway in human umbilical vein endothelial cellsKun-Ling Tsai, Yuh-Lih Chang, Po-Hsun Huang, et al.British Journal of Clinical Pharmacology|August 27, 2025
Effectiveness and safety of combining thiazides with loop diuretics vs. loop diuretics monotherapy in patients with acute decompensated heart failure: A retrospective cohort studyChia-Chen Hsu, Hsien-Chih Chiu, Ju-Chieh Wung, et al.Therapeutic Drug Monitoring|January 30, 2022
Drug-Drug Interactions With Cyclosporine in the Anti-Hepatitis C Viral PrOD Combination Regimen of Paritaprevir/Ritonavir-Ombitasvir and Dasabuvir in Organ Transplant Recipients With Severe Hepatic Fibrosis or CirrhosisYing-Yu Huang, Yu-Hsuan Huang, Tsai-Hung Wu, et al.Pageof 12